Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Bausch & Lomb Corp (BLCO)

Bausch + Lomb CEO Brent Saunders departs; Thomas Appio named interim CEO

Mixed Impact 4 of 5 leadership Written later

Brent Saunders left his roles as Bausch + Lomb chief executive and board member, effective October 12, 2026, under a mutually agreed separation. Thomas J. Appio, the board chairman who also serves as CEO of parent Bausch Health, was named interim CEO. The company said it expects to raise its full-year 2026 adjusted EBITDA guidance excluding Acquired IPR&D, based on preliminary third-quarter results.

Key points

  • Saunders' separation agreement provides a $75.5 million lump-sum cash payment and up to $50,000 in attorneys' fees, subject to a release of claims.
  • All of Saunders' outstanding equity awards, vested or unvested, were forfeited and cancelled.
  • Appio serves as interim CEO while remaining CEO of Bausch Health, the company's controlling shareholder.
  • The company expects to raise full-year 2026 adjusted EBITDA guidance excluding Acquired IPR&D; details are due with third-quarter results on October 28.

The filing

CompanyBausch & Lomb Corp (BLCO)
Form8-K, current report
Filed with the SECOct 13, 2026, 6:09 AM ET
Accession number0000950103-26-015460

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.